Robotic-assisted thoracic surgery for lung cancer showed a short learning curve and strong outcomes, with 5-year survival rates comparable to open surgery.

Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung ...

In an intriguing development, a study published in Biosensors and Bioelectronics suggests that honeybees might play a ...

Chest pain is one of the most common types of discomfort one can experience. This is because it can be caused by a number of health problems, including digestive issues, heart diseases, and lung ...

“While great strides have been made in the treatment of EGFR-mutated non-small cell lung cancer, a critical need still exists for treatment approaches that are not only effective but also more ...

A new study in England shows a strong link between higher rates of chest x-ray referrals in general practice patients with symptoms, such as persistent cough, and earlier lung cancer diagnoses, along ...

Objective: This study aims to investigate the relationship between nutritional status and quality of life (QOL) in patients with lung cancer, analyze the clinical application of nutritional support, ...

It just wouldn't go away. Finally ended up getting a chest x-ray and then a CT scan and a diagnosis in August 2020," Williams said. The diagnosis was lung cancer, leading to surgery to remove a tumor.

We appreciate the Correspondence from Elif Hindié and David Groheux highlighting two important points from our PET-based, pathological complete response-adapted PHERGain strategy. 1 This study met its ...

BioN­Tech has high­ly en­cour­ag­ing sur­vival da­ta for its bis­pe­cif­ic an­ti­body com­bin­ing check­point block­ade with VEGF-A in­hi­bi­tion as a first-line treat­ment for ...

BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. The biotech linked BNT327 to a median overall survival (OS) of 16.8 months in a Chinese ...

Targeted therapy in metastatic non–small cell lung cancer had a 62% survival advantage ... positron emission tomography (PET) scintigraphy, total expenditure on low-complexity outpatient tests ...